GANX
Gain Therapeutics·NASDAQ
--
--(--)
--
--(--)
GANX fundamentals
Gain Therapeutics (GANX) released its earnings on Aug 12, 2025: revenue was 0 (YoY 0.00%), met estimates; EPS was -0.19 (YoY +54.76%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.19
+54.76%
Report date
Aug 12, 2025
Earnings Call
4:00 PM on Aug 14, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
Key Indicators
Gain Therapeutics (GANX) key financial stats and ratios, covering profitability, financial health, and leverage.
Gain Therapeutics (GANX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Gain Therapeutics (GANX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Gain Therapeutics (GANX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Gain Therapeutics (GANX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Gain Therapeutics (GANX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for Gain Therapeutics next quarter?What were the key takeaways from Gain Therapeutics's earnings call?What is the revenue and EPS growth rate for Gain Therapeutics year over year?Did Gain Therapeutics beat or miss consensus estimates last quarter?What does Gain Therapeutics do and what are its main business segments?What is Gain Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Gain Therapeutics’s earnings call?What factors drove the changes in Gain Therapeutics's revenue and profit?
